2型糖尿病患者胰腺交感神经支配的无创成像
这项回顾性研究纳入25例2型糖尿病患者和64例无糖尿病者,均因嗜铬细胞瘤或副神经节瘤(或疑似)既往接受11C-HED-PET/CT,评估胰腺交感神经支配。结果显示2型糖尿病患者的胰腺CT衰减(HU)、11C-HED SBI和SBI FV较低,而SUVmean、FV和FNV相似,提示11C-HED-PET用于无创评估人胰腺交感神经支配具有可行性。
要点
- 2型糖尿病患者胰腺CT衰减(HU)、11C-HED SBI和SBI FV低于无糖尿病者
- 2型糖尿病患者与无糖尿病者的11C-HED SUVmean、FV和FNV相似
- 11C-HED-PET用于无创评估人胰腺交感神经支配具有可行性
核心结论
- 研究证明使用11C-HED-PET无创评估人胰腺交感神经支配具有可行性。
- 这些发现需进一步前瞻性评估,尤其是在胰腺交感神经支配存在理论缺陷的个体中,如1型糖尿病患者。
研究设计与样本
- 回顾性研究,纳入25例2型糖尿病患者和64例无糖尿病者,均因嗜铬细胞瘤或副神经节瘤(或疑似)既往接受11C-HED-PET/CT。
- 在整个胰腺及六个独立解剖胰腺区域评估11C-HED SUVmean、SBI、胰腺功能体积(FV,ml)、功能神经元体积(FNV,计算为SUVmean×FV)、SBI FV(计算为SBI×FV)及CT衰减(HU)。
主要发现
- 胰腺11C-HED摄取总体较高,个体间变异明显,提示交感神经支配存在变异性。
- 2型糖尿病患者胰腺CT衰减(HU)低于无糖尿病者(p<0.001)。
- 2型糖尿病患者11C-HED SBI低于无糖尿病者(p=0.0049)。
- 2型糖尿病患者SBI FV低于无糖尿病者(p=0.0142)。
- 2型糖尿病患者与无糖尿病者11C-HED SUVmean(p=0.15)、FV(p=0.73)和FNV(p=0.30)相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出这些发现需进一步前瞻性评估,尤其是在胰腺交感神经支配存在理论缺陷的个体中,如1型糖尿病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Compromised pancreatic sympathetic innervation has been suggested as a factor involved in both immune-mediated beta cell destruction and endocrine dysregulation of pancreatic islets. To further explore these intriguing findings, new techniques for in vivo assessment of pancreatic innervation are required. This is a retrospective study that aimed to investigate whether the noradrenaline (norepinephrine) analogue 11C-hydroxy ephedrine (11C-HED) could be used for quantitative positron emission tomography (PET) imaging of the sympathetic innervation of the human pancreas. METHODS: In 25 individuals with type 2 diabetes and 64 individuals without diabetes, all of whom had previously undergone 11C-HED-PET/CT because of pheochromocytoma or paraganglioma (or suspicion thereof), the 11C-HED standardised uptake value (SUVmean), 11C-HED specific binding index (SBI), pancreatic functional volume (FV, in ml), functional neuronal volume (FNV, calculated as SUVmean × FV), specific binding index with functional volume (SBI FV, calculated as SBI × FV) and attenuation on CT (HU) were investigated in the entire pancreas, and additionally in six separate anatomical pancreatic regions. RESULTS: Generally, 11C-HED uptake in the pancreas was high, with marked individual variation, suggesting variability in sympathetic innervation. Moreover, pancreatic CT attenuation (HU) (p<0.001), 11C-HED SBI (p=0.0049) and SBI FV (p=0.0142) were lower in individuals with type 2 diabetes than in individuals without diabetes, whereas 11C-HED SUVmean (p=0.15), FV (p=0.73) and FNV (p=0.30) were similar. CONCLUSIONS/INTERPRETATION: We demonstrate the feasibility of using 11C-HED-PET for non-invasive assessment of pancreatic sympathetic innervation in humans. These findings warrant further prospective evaluation, especially in individuals with theoretical defects in pancreatic sympathetic innervation, such as those with type 1 diabetes.
引用
- Vyakaranam AR, Mahamed MM, Hellman P, et al. Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes. Diabetologia. 2023. PMID: 37935826. doi:10.1007/s00125-023-06039-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。